Miracle Mile Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.1M | Buy |
67,878
+2,564
| +4% | +$552K | 0.2% | 94 |
|
|
2026
Q1 | $14.2M | Buy |
65,314
+2,827
| +5% | +$627K | 0.2% | 96 |
|
|
2025
Q4 | $14.3M | Buy |
62,487
+3,534
| +6% | +$805K | 0.2% | 97 |
|
|
2025
Q3 | $13.6M | Buy |
58,953
+5,026
| +9% | +$1.02M | 0.2% | 99 |
|
|
2025
Q2 | $10M | Buy |
53,927
+8,094
| +18% | +$1.5M | 0.17% | 98 |
|
|
2025
Q1 | $9.6M | Buy |
45,833
+1,831
| +4% | +$356K | 0.19% | 86 |
|
|
2024
Q4 | $7.82M | Buy |
44,002
+12,085
| +38% | +$2.22M | 0.16% | 101 |
|
|
2024
Q3 | $6.3M | Buy |
31,917
+2,244
| +8% | +$419K | 0.15% | 92 |
|
|
2024
Q2 | $5.09M | Buy |
29,673
+430
| +1% | +$71.2K | 0.12% | 105 |
|
|
2024
Q1 | $5.33M | Buy |
29,243
+1,801
| +7% | +$310K | 0.13% | 107 |
|
|
2023
Q4 | $4.25M | Buy |
27,442
+460
| +2% | +$67.1K | 0.12% | 117 |
|
|
2023
Q3 | $4.02M | Sell |
26,982
-3,353
| -11% | -$492K | 0.12% | 108 |
|
|
2023
Q2 | $4.09M | Sell |
30,335
-1,710
| -5% | -$251K | 0.12% | 116 |
|
|
2023
Q1 | $5.11M | Buy |
32,045
+812
| +3% | +$124K | 0.17% | 107 |
|
|
2022
Q4 | $5.05M | Buy |
31,233
+764
| +3% | +$117K | 0.17% | 108 |
|
|
2022
Q3 | $4.09M | Sell |
30,469
-4,402
| -13% | -$632K | 0.19% | 80 |
|
|
2022
Q2 | $5.34M | Sell |
34,871
-337
| -1% | -$51.5K | 0.25% | 72 |
|
|
2022
Q1 | $5.71M | Buy |
35,208
+2,507
| +8% | +$364K | 0.24% | 72 |
|
|
2021
Q4 | $4.43M | Buy |
32,701
+19,900
| +155% | +$2.35M | 0.17% | 109 |
|
|
2021
Q3 | $1.38M | Buy |
12,801
+6,114
| +91% | +$699K | 0.07% | 203 |
|
|
2021
Q2 | $753K | Sell |
6,687
-2,128
| -24% | -$240K | 0.04% | 222 |
|
|
2021
Q1 | $954K | Buy |
8,815
+127
| +1% | +$13.6K | 0.05% | 206 |
|
|
2020
Q4 | $934K | Buy |
8,688
+3,759
| +76% | +$361K | 0.06% | 211 |
|
|
2020
Q3 | $432K | Buy |
4,929
+2,149
| +77% | +$202K | 0.03% | 261 |
|
|
2020
Q2 | $273K | Sell |
2,780
-301
| -10% | -$26.5K | 0.02% | 272 |
|
|
2020
Q1 | $235K | Sell |
3,081
-3,517
| -53% | -$300K | 0.03% | 244 |
|
|
2019
Q4 | $584K | Buy |
6,598
+39
| +0.6% | +$3.24K | 0.04% | 182 |
|
|
2019
Q3 | $497K | Sell |
6,559
-1,248
| -16% | -$85.6K | 0.03% | 196 |
|
|
2019
Q2 | $568K | Buy |
7,807
+2,500
| +47% | +$197K | 0.04% | 178 |
|
|
2019
Q1 | $428K | Buy |
5,307
+100
| +2% | +$8.18K | 0.03% | 195 |
|
|
2018
Q4 | $480K | Sell |
5,207
-68
| -1% | -$5.98K | 0.06% | 89 |
|
|
2018
Q3 | $499K | Hold |
5,275
| – | – | 0.05% | 122 |
|
|
2018
Q2 | $489K | Buy |
5,275
+300
| +6% | +$29.3K | 0.05% | 116 |
|
|
2018
Q1 | $471K | Buy |
4,975
+200
| +4% | +$22K | 0.05% | 110 |
|
|
2017
Q4 | $462K | Buy |
+4,775
| New | +$450K | 0.07% | 61 |
|
Other funds holding ABBV
Miracle Mile Advisors's ABBV Position: Q2 2026 in Review
Miracle Mile Advisors increased its AbbVie (ABBV) stake by 3.9% in Q2 2026, buying an estimated $552K and bringing the position to 67,878 shares worth $17.1M. The position accounts for 0.2% of the portfolio, ranked #94.
Miracle Mile Advisors first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Miracle Mile Advisors held 67,878 shares of AbbVie worth $17.1M as of Q2 2026.
- Miracle Mile Advisors bought 2,564 AbbVie shares in Q2 2026, an estimated $552K.
- AbbVie made up 0.2% of Miracle Mile Advisors's portfolio in Q2 2026, its #94 holding.
- Miracle Mile Advisors first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
- 4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.